Announcement on the Participation of Wholly-Owned Subsidiary in Subscription of Industrial Fund and Related Transactions
Zhejiang Yatai Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the 13th meeting of the 8th Board of Directors on May 29, 2026, and approved the proposal regarding the participation of its wholly-owned subsidiary in the subscription of industrial funds and related transactions. The specific details are announced as follows:
I. Overview of External Investment
(1) Basic Information of the Investment
The Company's wholly-owned subsidiary, Zhejiang Yatai Lizhong Holdings Co., Ltd. (hereinafter referred to as "Yatai Lizhong"), intends to invest RMB 15 million as a limited partner with Beijing Zheshang Huaying Venture Capital Management Co., Ltd. (hereinafter referred to as "Zheshang Huaying") and Zhejiang Fulai Ente Holdings Co., Ltd. (hereinafter referred to as "Fulai Ente") to establish Hangzhou Qizhen Zhijian Equity Investment Partnership (Limited Partnership) (tentative name, subject to the final approval by the market supervision and management department, hereinafter referred to as "Qizhen Zhijian"). The partnership agreement was signed on May 29, 2026. Yatai Lizhong also plans to invest RMB 10 million as a limited partner with Zheshang Huaying, Beijing Sunshine Nuohua Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Sunshine Nuohua"), Fulai Ente, and Jiang Mingming to establish Hangzhou Qizhen Zhikang Equity Investment Partnership (Limited Partnership) (tentative name, subject to the final approval by the market supervision and management department, hereinafter referred to as "Qizhen Zhikang"). The partnership agreement was also signed on May 29, 2026. The total subscription scale for Qizhen Zhijian and Qizhen Zhikang is RMB 42.5 million and RMB 26.5 million, respectively, with Zheshang Huaying serving as the executive partner and fund manager. The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or major omissions.
(2) Related Transactions
Zheshang Huaying, the executive partner of Qizhen Zhijian and Qizhen Zhikang, is a concerted actor of the Company's controlling shareholder, Zhejiang Xingchen Equity Investment Partnership (Limited Partnership), which holds 48,420,252 shares of the Company, accounting for 6.49% of the total share capital. Mr. Yang Zhilong, a director of the Company, is the manager of Zheshang Huaying, and Mr. Zong Hao, the Company’s secretary of the Board, is a representative appointed by the executive partner of Zhejiang Xingchen Equity Investment Partnership (Limited Partnership). According to the "Shenzhen Stock Exchange Stock Listing Rules," this external investment constitutes a related transaction but does not constitute a major asset restructuring as defined by the "Measures for the Administration of Major Asset Restructuring of Listed Companies."
(3) Review Situation
The Company held the 13th meeting of the 8th Board of Directors on May 29, 2026, where related directors Mr. Qiu Zhongxun, Mr. Zong Hao, Mr. Yang Zhilong, Mr. Chen Xiaobiao, Ms. Cheng Nana, and Mr. Han Junlei abstained from voting. The proposal was approved with 3 votes in favor, 0 votes against, and 0 abstentions. The independent directors of the Company held a special meeting of the 8th Board of Directors on the fourth meeting of 2026 to review this external investment matter, and all independent directors unanimously agreed to the matter and consented to submit the proposal to the Board of Directors for review. According to the "Shenzhen Stock Exchange Stock Listing Rules" and the "Articles of Association," this related transaction does not require submission to the shareholders' meeting for review.
II. Basic Information of Related Parties and Related Relationships
- Company Name: Beijing Zheshang Huaying Venture Capital Management Co., Ltd.
- Unified Social Credit Code: 911101055844820810
- Address: Room C903-14, 9th Floor, No. 8 Kaiyang Road, Fengtai District, Beijing
- Legal Representative: Zhu Jin
- Registered Capital: RMB 20 million
- Date of Establishment: September 30, 2011
- Business Scope: Investment management; asset management.